Apr 2, 2026globenewswire.comGet Summer-Season Ready with New Notorious Fitness Training PlansgeneralFood & Lifestyle
Apr 2, 2026globenewswire.comVericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBridgeneralMeasuring Aging
Apr 2, 2026nature.comLongitudinal changes in epigenetic clocks predict survival in the InCHIANTI cohortlandmarkMeasuring Aging
Apr 2, 2026nature.comLongitudinal changes in epigenetic clocks predict long-term mortalitysignificantMeasuring Aging
Apr 2, 2026fiercebiotech.comPremier Radiology acquires teleradiology specialist GLOBISgeneralIndustry & Access
Apr 2, 2026nature.comSpontaneous aging-associated inflammation and genome instability in the immune system of turquoise killifishgeneral
Apr 2, 2026globenewswire.comCherry-Picking Science: WVA Condemns EU Tobacco ReportgeneralFood & Lifestyle
Apr 2, 2026globenewswire.comEYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)generalIndustry & Access
Apr 2, 2026investor.lilly.comLa FDA aprueba Foundayo™ (orforglipron) de Lilly, la única pastilla GLP-1 para la pérdida de peso que puede tomarse a cualquier hora del día sin restricciones de comida o aguageneralTreatments & Drugs
Apr 2, 2026investor.lilly.comLa FDA aprueba Foundayo™ (orforglipron) de Lilly, la única pastilla GLP-1 para la pérdida de peso que puede tomarse a cualquier hora del día sin restricciones de comida o agualandmarkIndustry & Access
Apr 2, 2026globenewswire.comMedicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Supportgeneral
Apr 2, 2026globenewswire.comGlobal Virus Network Meeting Advances a Science-Driven Agenda for Pandemic PreparednessgeneralFood & Lifestyle
Apr 2, 2026globenewswire.comAssisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030 | MarketsandMarkets™generalTreatments & Drugs
Apr 2, 2026globenewswire.comPaul Markovich Discusses Healthcare Reform Through the Worthy Movement on YourUpdateTVgeneral
Apr 2, 2026globenewswire.comCuronix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives NationwidegeneralIndustry & Access
Apr 2, 2026globenewswire.comGeneProof Announces CMV IVDR Launch on the myCROBE™ Fully Automated System for Transplant Caregeneral
Apr 2, 2026sciencedaily.comEating more meat may lower Alzheimer’s risk for some peoplesignificantMeasuring Aging
Apr 2, 2026sciencedaily.comBreakthrough could protect the vision cells that let you see faces and colorsgeneralTreatments & Drugs
Apr 2, 2026globenewswire.comUltragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)generalScience & Tech
Apr 2, 2026globenewswire.comBionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myelomageneral
Apr 2, 2026globenewswire.comMDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board membergeneral
